摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1R,2R,4S,5S,6S)-8,8-dimethyl-2-(phenylmethoxymethyl)-7,9-dioxatricyclo[4.3.0.02,4]nonan-5-ol | 156126-13-5

中文名称
——
中文别名
——
英文名称
(1R,2R,4S,5S,6S)-8,8-dimethyl-2-(phenylmethoxymethyl)-7,9-dioxatricyclo[4.3.0.02,4]nonan-5-ol
英文别名
——
(1R,2R,4S,5S,6S)-8,8-dimethyl-2-(phenylmethoxymethyl)-7,9-dioxatricyclo[4.3.0.02,4]nonan-5-ol化学式
CAS
156126-13-5
化学式
C17H22O4
mdl
——
分子量
290.359
InChiKey
JBKUESGTXDZTBE-MDLJMBGESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    408.2±30.0 °C(Predicted)
  • 密度:
    1.216±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.65
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Adenine Nucleotide Analogues Locked in a Northern Methanocarba Conformation:  Enhanced Stability and Potency as P2Y1 Receptor Agonists
    摘要:
    Preference for the Northern (N) ring conformation of the ribose moiety of nucleotide 5'-triphosphate agonists at P2Y(1), P2Y(2), P2Y(4), and P2Y(11) receptors, but not P2Y(6) receptors, was established using a ring-constrained methanocarba (a 3.1.0-bicyclohexane) ring as a ribose substitute (Kim et al. J. Med. Chem. 2002, 45, 208-218.). We have now combined the ring-constrained (N)-methanocarba modification of adenine nucleotides with other functionalities known to enhance potency at P2 receptors. The potency of the newly synthesized analogues was determined in the stimulation of phospholipase C through activation of turkey erythrocyte P2Y, or human P2Y, and P2Y2 receptors stably expressed in astrocytoma cells. An (N)methanocarba-2-methylthio-ADP analogue displayed an EC50 at the hP2Y(1) receptor of 0.40 nM and was 55-fold more potent than the corresponding triphosphate and 16-fold more potent than the riboside 5'-diphosphate. 2-Cl-(N)-methanocarba-ATP and its N-6-Me analogue were also highly selective, full agonists at P2Y, receptors. The (N)-methanocarba-2-methylthio and 2-chloromonophosphate analogues were full agonists exhibiting micromolar potency at P2Y(1) receptors, while the corresponding ribosides were inactive. Although beta,y-methylene-ATP was inactive at P2Y receptors beta,y-methylene-(N)-methanocarba-ATP was a potent hP2Y1 receptor agonist with an EC50 of 160 nM and was selective versus hP2Y(2) and hP2Y(4) receptors. The rates of hydrolysis of Northern (N) and Southern (S) methanocarba analogues of AMP by rat 5'-ectonucleotidase were negligible. The rates of hydrolysis of the corresponding triphosphates by recombinant rat NTPDase 1 and 2 were studied. Both isomers were hydrolyzed by NTPDase 1 at about half the rate of ATP hydrolysis. The (N) isomer was hardly hydrolyzed by NTPDase 2, while the (S) isomer was hydrolyzed at one-third of the rate of ATP hydrolysis. This suggests that new, more stable and selective nucleotide agonists may be designed on the basis of the (N)-conformation, which greatly enhanced potency at P2Y, receptors.
    DOI:
    10.1021/jm010538v
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Anti-HIV Activity of Carbocyclic Ring-Enlarged 4′,1′a-Methano Oxetanocin Analogues
    摘要:
    Synthesis of carbocyclic ring-enlarged 4',1'a-methano oxetanocin analogues via completely regioselective opening of cyclic sulfites by sodium azide or purine bases is described.
    DOI:
    10.1080/07328319708006132
点击查看最新优质反应信息

文献信息

  • Synthesis Using Ring Closure Metathesis and Effect on Nucleoside Transport of a (N)-Methanocarba <i>S</i>-(4-Nitrobenzyl)thioinosine Derivative
    作者:Kyeong Lee、Carol Cass、Kenneth A. Jacobson
    DOI:10.1021/ol006999c
    日期:2001.2.1
    [reaction: see text] A new synthetic route to ring-constrained (N)-methanocarba nucleosides and nucleotides is presented. Ring closure of a diene intermediate using Grubbs catalyst provides a new avenue for the preparation of the cyclopentenone derivative 6, which is a versatile intermediate for various carbocycles. The product was almost as potent an inhibitor of es-mediated nucleoside transport as
    [反应:见正文] 提出了环约束(N)-甲烷卡巴核苷和核苷酸的新合成路线。使用格鲁布斯催化剂使二烯中间体闭环,为环戊烯酮衍生物6的制备提供了新途径,环戊烯酮衍生物6是各种碳环的通用中间体。该产品几乎与母体化合物一样有效,是 es 介导的核苷转运抑制剂,在大约 30-50 nM 的浓度下,可将培养的 CCRF-CEM 细胞中尿苷的初始摄取率抑制 50%。
  • Synthesis of Cyclopropyl-Fused Carbocyclic Nucleosides via the Regioselective Opening of Cyclic Sulfites
    作者:Hyung Ryong Moon、Hea Ok Kim、Moon Woo Chun、Lak Shin Jeong、Victor E. Marquez
    DOI:10.1021/jo990010m
    日期:1999.6.1
    The syntheses of some carbocyclic nucleosides that are conformationally locked as "northern" mimics of antiviral active, ring-expanded oxetanocin analogues are reported. The target compounds derived their rigid conformation from a common bicyclo[3.1.0]hexane template. The uracil (3a), cytosine (3b), and adenine (3c) analogues were synthesized from an intermediate cyclic sulfite (12a) that underwent
    据报道,某些碳环核苷的合成被构象锁定为抗病毒活性,扩环的氧杂环丁烷类似物的“北方”模拟物。目标化合物从常见的双环[3.1.0]己烷模板获得其刚性构象。尿嘧啶(3a),胞嘧啶(3b)和腺嘌呤(3c)类似物是由中间体环状亚硫酸盐(12a)合成的,该中间体经过亲核试剂选择性开环。12a与叠氮的反应可在嘧啶环建成后提供尿嘧啶胞嘧啶类似物(3a和3b),而与腺嘌呤钠盐的反应则提供了一种有效的3c收敛方法。由12a与2-氨基-6-氯嘌呤偶联获得的不期望的N-7区域异构体占优势。因此,将二醇衍生物11选择性地保护并在Mitsunobu条件下偶联,以在脱保护后得到所需的鸟嘌呤类似物3d。除鸟嘌呤类似物外,本文所述的环亚硫酸化学代表了一种有用的替代方法,可作为碳环核苷的一般方法。目标核苷3a-d均未显示出对HIV-1,HSV-1,HSV-2和HCMV的显着抗病毒活性。相对于已显示出良好的抗HSV和抗
  • Use of a cyclic sulfite as an epoxide surrogate in the regioselective synthesis of a carbocyclic ring-enlarged 4′,1′a-methano oxetanocin analogue
    作者:Lak S. Jeong、Victor E. Marquez
    DOI:10.1016/0040-4039(96)00289-4
    日期:1996.4
    Although cyclic sulfites are less reactive than their cyclic sulfate counterparts, the present work shows that cyclic sulfite 15a is a useful synthon for the convergent synthesis of carbocyclic nucleosides. Target compound 6, which represents a rigid carbocyclic nucleoside mimic of anti-HIV active 9-[2′,3′-dideoxy-3′-C-(hydroxymethyl)-β-erythro-pentofuranosyl]adenine (3), was obtained after regioselective
    尽管环状亚硫酸盐的反应性比环状硫酸盐的反应性低,但目前的工作表明,环状亚硫酸盐15a是碳环核苷聚合合成的有用合成子。获得了目标化合物6,该化合物代表抗HIV活性9- [2',3'-二脱氧-3'- C-(羟甲基)-β-赤型-戊呋喃糖基]腺嘌呤的刚性碳环核苷类似物(3),15a具有腺嘌呤的区域选择性开环和自由基诱导的额外羟基脱氧。
  • Methanocarba Analogues of Purine Nucleosides as Potent and Selective Adenosine Receptor Agonists
    作者:Kenneth A. Jacobson、Xiao-duo Ji、An-Hu Li、Neli Melman、Maqbool A. Siddiqui、Kye-Jung Shin、Victor E. Marquez、R. Gnana Ravi
    DOI:10.1021/jm9905965
    日期:2000.6.1
    (N)-Methanocarba analogues of various N(6)-substituted adenosine derivatives, including cyclopentyl and 3-iodobenzyl, in which the parent compounds are potent agonists at either A(1) or A(3) receptors, respectively, were synthesized. The N(6)-cyclopentyl derivatives were A(1) receptor-selective and maintained high efficacy at recombinant human but not rat brain A(1) receptors, as indicated by stimulation of binding
    腺苷受体激动剂具有心脏保护、脑保护和抗炎特性。我们报告核糖部分纳入环约束的碳环修饰是设计具有良好药效学特性的 A(1) 和 A(3) 受体激动剂的一般方法。虽然腺苷激动剂的简单碳环取代大大降低了效力,但甲卡巴-腺苷类似物现在已经确定了糖褶皱在稳定活性腺苷受体结合构象中的作用,从而可以识别出一种有利的异构体。在此类类似物中,稠合环丙烷部分将核苷的假糖环限制为北(N)或南(S)构象,如假旋转循环中所定义。在 A(1)、A(2A) 和 A(3) 受体的结合试验中,(N)-methanocarba-腺苷比 (S)-类似物具有更高的亲和力,特别是在人类 A(3) 受体上(N/S 亲和力比为 150)。(N)-Methanocarba 类似物的各种 N(6)-取代的腺苷生物,包括环戊基和 3-苄基,其中母体化合物分别是 A(1) 或 A(3) 受体的有效激动剂,被合成。N(6)-环戊基衍生物对 A(1)
  • Synthesis and purine receptor affinity of 6-oxopurine nucleosides and nucleotides containing (N)-methanocarba-pseudoribose rings
    作者:Gnana Ravi、Kyeong Lee、Xiao-duo Ji、Hak Sung Kim、Kelly A. Soltysiak、Victor E. Marquez、Kenneth A. Jacobson
    DOI:10.1016/s0960-894x(01)00450-4
    日期:2001.9
    6-Oxopurine derivatives containing a northern (N) methanocarba modification (i.e., fused cyclopropane and cyclopentane rings in place of the ribose) were synthesized and the adenosine receptor affinity measured. Guanine or hypoxanthine was coupled at the 7-position, or 1,3-diblitylxanthine was coupled at the 9-position. The pseudoribose ring was also substituted at the 5 ' -position with an N-methyluronamide or with phosphate groups. Published by Elsevier Science Ltd.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫